Through our state of the art nanomaterial technology, nano-hydroxapatite crystals are successfully grown on nano-co-polymers. The sub-100nm nano-hydroxyapatite crystals have shown the same electron diffraction pattern as human hydroxyapatite crystals extracted from trabeculae in selected area electron diffraction (SAED) in TEM. Sub-500nm nano-co-polymers allow seamless distribution with the polymer matrix which resemble the FDM filament.  

In OSSFILA, all nano-particles and crystals are synthesized in industrial scale under close supervision of our engineers and scientists. The incorporation of nano-particles in the polymer matrix during filament extrusion is engineered to produce excellent dispersion and to perfect the printing experience in any commercial 3D printer. All the manufacturing processes are done in ISO 14644-1 Class 10,000 cleanroom and is under strict quality control governed by ISO 13485. 

Bonlecule is a groundbreaking functional biomaterial. It has superior biological and mechanical properties compared to any biomaterial building block on the market. Conventional biomaterials improve on bioactivity through filler materials or coatings. In FDM filament, filler materials will contribute to the brittleness and filament may break at the printer nozzle. Coating is also not possible for making uniform continuum required for 3D printing. The solution to this limitation is to utilize bioactive nano-particles with engineered dispersion process during production.